Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients

Inclusion Criteria

• •Age greater than or equal to 13 years.
• •Receiving CsA or tacrolimus from the time of transplantation or within 2 weeks thereafter
• •Patients with a functioning allograft and a Nankivell GFR greater than or equal to 20 mL/min, within 2 weeks before randomization